We introduce a “backward” Bayesian method to assist sponsors formulating early phase Go/No-Go criteria based on the ultimate efficacy or safety target, which is usually clearer for Phase 3. Derived fr
This statistic shows what in-house counsel in organizations in the U.S. and Europe looks for when considering outside counsel in 2021. During the survey, 68 percent of respondents said that they looke
